Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

NCT00654498 ·Status: COMPLETED ·Phase: PHASE3

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

NCT00472199 ·Status: COMPLETED ·Phase: PHASE4

A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

NCT00349531 ·Status: COMPLETED ·Phase: PHASE4

Pramipexole (BI-Sifrol®) Orally Once Daily for 6 Weeks in Patients With Primary Restless Legs Syndrome

NCT00152997 ·Status: COMPLETED ·Phase: PHASE2

Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)

NCT00887289 ·Status: COMPLETED

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole

NCT00344994 ·Status: COMPLETED ·Phase: PHASE4

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

NCT00152958 ·Status: COMPLETED ·Phase: PHASE3

Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

NCT05214963 ·Status: COMPLETED ·Phase: NA

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

NCT00806026 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

NCT00133198 ·Status: COMPLETED ·Phase: PHASE3

R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis

NCT00140218 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)

NCT04874155 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

NCT01521663 ·Status: COMPLETED ·Phase: PHASE2

Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day

NCT00596115 ·Status: TEMPORARILY_NOT_AVAILABLE

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

NCT01386944 ·Status: COMPLETED

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

NCT00375284 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

NCT00225862 ·Status: COMPLETED ·Phase: PHASE3

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

NCT00051961 ·Status: COMPLETED

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

NCT00314860 ·Status: COMPLETED ·Phase: PHASE3

Long-term Study Of Ropinirole In Restless Legs Syndrome

NCT00329602 ·Status: COMPLETED ·Phase: PHASE4

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

NCT05196828 ·Status: COMPLETED ·Phase: NA

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

NCT02231918 ·Status: COMPLETED ·Phase: PHASE2

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome

NCT00355641 ·Status: COMPLETED ·Phase: PHASE3

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

NCT00140712 ·Status: COMPLETED ·Phase: PHASE1

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00403104 ·Status: COMPLETED ·Phase: PHASE2